Consolidated Statement of Changes in Stockholders' Equity (Deficiency) - USD ($)		Members' Equity (Deficiency) [Member]	Members' Equity (Deficiency) [Member] Pre Titan Merger [Member]	Preferred Stock [Member] Series A Preferred Stock [Member]		Preferred Stock [Member] Series A Preferred Stock [Member] Pre Titan Merger [Member]	[1]	Preferred Stock [Member] Series B Preferred Stock [Member]	[2]	Preferred Stock [Member] Series B Preferred Stock [Member] Pre Titan Merger [Member]	[2]	Preferred Stock [Member] Series B Redeemable Convertible Preferred Stock [Member]	Common Stock [Member]	Common Stock [Member] Pre Titan Merger [Member]	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member] Pre Titan Merger [Member]	Retained Earnings [Member]	Retained Earnings [Member] Pre Titan Merger [Member]	Series B Preferred Stock [Member]	Total	Pre Titan Merger [Member]	Series B Redeemable Convertible Preferred Stock [Member]
Balance at Dec. 31, 2022		$ 2,526,104			[1]															$ 2,526,104
Balance, shares at Dec. 31, 2022
Balance, value at Dec. 31, 2022		2,526,104
Balance, shares at Dec. 31, 2022					[1]
Issuance of warrants					[1]										1,375,000		(1,075,000)			300,000
Effect of reverse acquisition		(2,031,503)		$ 63	[1]			$ 147					$ 3,395		30,088,068		(664,601)			27,395,569
Effect of reverse acquisition, shares				630,900	[1]			1,470,135					33,952,778
Stock-based compensation				$ 7	[1]								$ 30		5,590,448					5,590,485
Net loss			$ (664,601)		[1]												(148,340,448)			(148,340,448)	$ (664,601)
Settlement of note due to contribution		170,000			[1]															170,000
Share-based compensation, shares				70,100	[1]								300,000
Cancelation of Series C Preferred Stock for options				$ (7)	[1]										7
Cancelation of Series C Preferred Stock for options, shares	[1]			(70,100)
Exchange of debt, preferred stock and common stock for common stock rights					[1]			$ (147)					$ (1,912)		118,324,275					118,322,216
Exchange of debt, preferred stock and common stock for common stock rights, shares								(1,470,135)					(19,118,233)
Balance at Dec. 31, 2023				$ 63	[1]								$ 1,513		155,377,798		(150,080,049)			5,299,325
Balance, shares at Dec. 31, 2023																						0
Balance, value at Dec. 31, 2023
Balance, shares at Dec. 31, 2023				630,900	[1]								15,134,545
Issuance of warrants					[1]										3,958,982		(862,289)			3,096,693
Issuance of common stock due to exercise of share rights					[1]								$ 1,308		(1,308)
Exercise of share pre warrants, shares													13,077,408
Series B Preferred Offering					[1]										2,653,105					2,653,105
Series B Preferred Offering, shares												422,200							422,200
Series B Preferred Offering												$ 1,568,895
Series B Preferred Offering costs					[1]										(290,390)					(290,390)
Series A Preferred shares issued in relation to guarantee agreement				$ 22	[1]										3,009,978					3,010,000
Series A Preferred shares issued in relation to guarantee agreement, shares	[1]			215,000
Effect of reverse acquisition				$ 55	[1]										8,567,945					8,568,000
Effect of reverse acquisition, shares	[1]			552,000
Issuance of series B preferred					[1]										(1,322,696)					(1,322,696)
Issuance of Series B preferred, shares												105,592
Issuance of Series B preferred												$ 1,372,696
Issuance of series B preferred due to extinguishment of debt					[1]
Issuance of series B preferred due to extinguishment of debt, shares												50,453
Issuance of series B preferred due to extinguishment of debt												$ 655,889
Remeasurement of Series B Preferred Stock to redemption value					[1]										(4,249,599)					(4,249,599)
Remeasurement of Series B Preferred Stock to redemption value												$ 4,249,599
Stock-based compensation					[1]										65,293					65,293
Net loss					[1]												(21,543,305)			(21,543,305)
Balance at Dec. 31, 2024				$ 140	[1]								$ 2,821		$ 167,769,108		$ (172,485,643)			$ (4,713,574)
Balance, shares at Dec. 31, 2024												578,245										578,245
Balance, value at Dec. 31, 2024												$ 7,847,079
Balance, shares at Dec. 31, 2024				1,397,900	[1]								28,211,953

[1] On January 10, 2024, the Company redomiciled and exchanged all outstanding shares of its pre-existing Series C Preferred Stock for shares of a new class of Series A Preferred Stock (Note 1 – Organization and Nature of Operations). The Statement of Changes in Stockholders’ Equity (Deficiency) for the year ended December 31, 2023 has been retrospectively restated to reflect this change.

[2] On January 10, 2024, the Company redomiciled and its pre-existing Series A class of Preferred Stock and Series B class of Preferred stock were eliminated (Note 1 – Organization and Nature of Operations). The Statement of Changes in Stockholders’ Equity (Deficiency) for the year ended December 31, 2023 has been retrospectively restated to reflect these changes.